Hoya Vision Care has shared the latest findings of the clinical application of the MiYOSMART spectacle lens, and its role in myopia management, at

In a multi-racial cohort of Australian children, 0.01% atropine eyedrops were safe, well-tolerated and had a modest myopia control effect, according to a single-centre,

Patricia Sparrow will finish her tenure as CEO of Vision 2020 Australia at the end of 2022 to take up a new role as

Two experienced women in eye care, Gail Giordani and Jacque Katsieris, have been elected to the Optical Distributors and Manufacturers Australia (ODMA) Board.